Phase-in for Standardized Approach Treatment of Equity Exposures
Effective from Dec 28 2022 - Dec 27 2022
To view other versions open the versions tab on the right
| 17.1 | The risk weight treatment described in paragraph 7.50 will be subject to a five-year linear phase-in arrangement from 1 January 2023. For speculative unlisted equity exposures, the applicable risk weight will start at 100% and increase by 60 percentage points at the end of each year until the end of Year 5. For all other equity holdings, the applicable risk weight will start at 100% and increase by 30 percentage points at the end of each year until the end of Year 5. | |||